Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.571
EU - Europa 5.396
AS - Asia 2.988
SA - Sud America 126
AF - Africa 33
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 21
Totale 18.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.380
SG - Singapore 1.206
DE - Germania 973
RU - Federazione Russa 921
CN - Cina 892
SE - Svezia 850
IE - Irlanda 673
IT - Italia 637
UA - Ucraina 543
HK - Hong Kong 405
GB - Regno Unito 263
CA - Canada 180
FI - Finlandia 134
VN - Vietnam 132
AT - Austria 112
BR - Brasile 109
FR - Francia 104
IN - India 75
DK - Danimarca 67
ID - Indonesia 65
KR - Corea 59
JP - Giappone 42
NL - Olanda 38
TR - Turchia 28
IR - Iran 23
BE - Belgio 21
MY - Malesia 21
PL - Polonia 19
EU - Europa 18
NZ - Nuova Zelanda 17
ZA - Sudafrica 15
AU - Australia 13
CZ - Repubblica Ceca 9
EG - Egitto 9
ES - Italia 7
MX - Messico 7
AR - Argentina 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
SA - Arabia Saudita 4
BD - Bangladesh 3
IQ - Iraq 3
KG - Kirghizistan 3
PK - Pakistan 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NG - Nigeria 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 18.165
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Woodbridge 819
Singapore 790
Chandler 706
Dublin 653
Jacksonville 543
Houston 525
Fairfield 455
Wilmington 446
Frankfurt am Main 445
Dearborn 424
Hong Kong 384
Ashburn 374
New York 277
Milan 253
Princeton 244
Santa Clara 236
Seattle 175
Nanjing 173
Boardman 170
Cambridge 137
Shanghai 117
Vienna 108
Lachine 89
Dong Ket 78
Moscow 74
Altamura 73
Lawrence 71
Beijing 67
Jakarta 61
Guangzhou 60
Nanchang 59
Los Angeles 52
Council Bluffs 49
Fremont 45
Andover 42
Shenyang 42
Grafing 40
Toronto 38
Jinan 36
Jiaxing 34
Chicago 33
Nürnberg 33
San Diego 31
Helsinki 29
Falls Church 26
Ottawa 26
Tianjin 25
Zhengzhou 25
Daejeon 24
Kunming 23
Mountain View 23
Hangzhou 22
Hebei 22
Pune 22
The Dalles 22
Changsha 21
Brussels 20
Sacramento 19
Dallas 18
Hefei 17
Leawood 16
Nuremberg 16
Rome 15
Ningbo 14
Philadelphia 14
Phoenix 14
Edmonton 13
Huizen 13
Bergamo 12
Carate Brianza 12
London 12
Norwalk 12
Pasir Mas 12
Regensburg 12
Shinjuku 12
Turku 12
Taizhou 11
Auburn Hills 10
Munich 10
Kiev 9
San Francisco 9
San Mateo 9
Yongin-si 9
Cagliari 8
Codroipo 8
Rio de Janeiro 8
Tehran 8
Canazei 7
Detroit 7
São Paulo 7
Tokyo 7
Washington 7
Wuhan 7
Brooklyn 6
Changchun 6
Düsseldorf 6
Fuzhou 6
Lissone 6
Mainz 6
Totale 12.212
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 341
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 316
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 316
Age-related changes in the function and structure of the peripheral sensory pathway in mice 312
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 304
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 257
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 255
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 242
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 238
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 238
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 235
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 223
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 219
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 216
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 212
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 211
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 211
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 210
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 203
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 200
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 200
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 200
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 199
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 195
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 194
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 193
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 192
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 190
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 187
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 184
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 183
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 176
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 176
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 174
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 173
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 173
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 172
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 170
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 169
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 169
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 168
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 167
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 167
Lipoplatin tm: a less neurotoxic formulation of cisplatin 167
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 166
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 164
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 162
Erythropoietin both protects from and reverses experimental diabetic neuropathy 162
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 162
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 161
Granulocytes in actively induced Lewis rat EAE 160
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 157
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 154
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 154
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 154
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 151
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 150
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 149
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 149
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 148
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 147
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 147
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 147
Multimodal experimental approach to the study of human neurological diseases 147
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 147
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 145
Regression of diabetic complications by islet transplantation in the rat 144
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 143
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 142
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 139
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 138
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 138
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 137
Effect of proteasome inhibition on the central and peripheral nervous system 136
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 135
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 135
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 133
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 130
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 130
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 129
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 128
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 126
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 123
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 123
Characterization of Glutamate Transporters in Peripheral Nervous System. 122
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 119
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 118
Biodistrubution and toxicology of two PFCs intravenously injected in rats 117
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 116
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 115
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 111
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 109
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 109
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 109
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 108
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 107
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS 106
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics? 106
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 106
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 105
Totale 16.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020233 0 0 0 0 0 0 0 0 0 0 199 34
2020/20212.346 128 76 259 252 205 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20253.804 283 607 355 210 350 119 203 169 477 616 415 0
Totale 19.068